Skip to menu Skip to content Skip to footer
Dr Fernanda Cardoso
Dr

Fernanda Cardoso

Email: 
Phone: 
+61 7 344 33402

Overview

Background

Dr Fernanda Cardoso is a Brazil-born Australian dual-citizen researcher interested in venom peptide-based biodiscovery and therapeutics development. Cardoso was awarded an MSc in Molecular Pharmacology and a PhD with an emphasis in Biochemistry and Immunology and is part of the Institute for Molecular Bioscience, where she develops novel therapies for complex neurological diseases. Cardoso has interdisciplinary training in the fields of neuropharmacology, medicinal chemistry and chemical biology and a strong background in drug discovery, which provides the skills to identify naturally occurring or synthetic bioactive molecules and to study their effects in human physiology with applications in neurologic disorders such as chronic pain, irritable bowel syndrome (IBS), and motor neuron disease (MND). Please see Dr Cardoso’s Grants and Publications list for more details.

Before joining the University of Queensland, Dr Cardoso was part of the Queensland Institute for Medical Research, holding a prestigious CAPES Postdoctoral Fellowship. During this period, Cardoso developed unique high-throughput screen platforms for discovering protein and peptide targets of novel therapies to combat infectious diseases and novel helminth-derived bioactives with anti-inflammatory properties. Please see Dr Cardoso’s Publications list for more details.

Dr Cardoso is currently part of the Centre for Drug Discovery and manages several industry and academic projects studying ion channel modulators derived from natural repertoires, particularly venoms, and developing novel, effective drugs to treat neurological disorders.

Availability

Dr Fernanda Cardoso is:
Available for supervision
Media expert

Qualifications

  • Bachelor, Universidade Federal de Minas Gerais (UFMG)
  • Masters (Research) of Biological Sciences, Universidade Federal de Minas Gerais (UFMG)
  • Doctor of Philosophy, Universidade Federal de Minas Gerais (UFMG)

Research interests

  • Chronic pain - Pathophysiologcal mechanisms and Therapeutics development, Visceral Pain, Irritable Bowel Syndrome

  • Neurodegeneration - Pathophysiologcal mechanisms and Therapeutics development

  • Venomics and Pharmacology of Spiders, Cone snails and Snake venoms

  • Structure-function properties of venom peptides and proteins

  • Voltage-gated Ion Channels

Research impacts

Dr. Fernanda Cardoso's research has provided remarkable insights into the discovery and biology of new agents for therapeutical use in complex disorders such as chronic pain, irritable bowel syndrome and motor neuron disease, and vaccinology against tropical diseases. Her ongoing research in ion channel modulators has provided unique leads for treating neuropathic pain and neurodegenerative disorders, which could improve the lives of millions of individuals around the globe, and her past discoveries in vaccine research have the potential to improve the lives of millions of people in Africa, Asia and South America through a vaccine against schistosomiasis.

Works

Search Professor Fernanda Cardoso’s works on UQ eSpace

130 works between 2003 and 2025

121 - 130 of 130 works

2008

Journal Article

Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection

Cardoso, Fernanda C., Macedo, Gilson C., Gava, Elisandra, Kitten, Gregory T., Mati, Vitor L., de Melo, Alan L., Caliari, Marcelo V., Almeida, Giulliana T., Venancio, Thiago M., Verjovski-Almeida, Sergio and Oliveira, Sergio C. (2008). Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Neglected Tropical Diseases, 2 (10) e308, e308.1-e308.10. doi: 10.1371/journal.pntd.0000308

Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection

2008

Conference Publication

Vaccines against Schistosomiasis: production of single and chimeric tegument antigens for pre-clinical and clinical studies

Cardoso, F. C., Pearson, M., Giacomoantonio, P., Tribolet, L., Pickering, D., Shoemaker, C., Oliveira, S. C. and Loukas, A. (2008). Vaccines against Schistosomiasis: production of single and chimeric tegument antigens for pre-clinical and clinical studies. 11th Symposium of Schistosomiasis, Salvador, BA, Brazil, 20-22 August 2008.

Vaccines against Schistosomiasis: production of single and chimeric tegument antigens for pre-clinical and clinical studies

2007

Other Outputs

Membrane protein Sm29 of S. mansoni and uses thereof as vaccine and for diagnosing of schistosomiasis

Cardoso, F. C. and Oliveira, S. C. (2007). Membrane protein Sm29 of S. mansoni and uses thereof as vaccine and for diagnosing of schistosomiasis. WO 2007118292 A2.

Membrane protein Sm29 of S. mansoni and uses thereof as vaccine and for diagnosing of schistosomiasis

2007

Journal Article

The role of the vacB gene in the pathogenesis of Brucella abortus

Miyoshi, Anderson, Rosinha, Gracia M.S., Camargo, Ilana L.B.C., Trant, Cyntia M.C., Cardoso, Fernanda C., Azevedo, Vasco and Oliveira, Sergio C. (2007). The role of the vacB gene in the pathogenesis of Brucella abortus. Microbes and Infection, 9 (3), 375-391. doi: 10.1016/j.micinf.2006.12.004

The role of the vacB gene in the pathogenesis of Brucella abortus

2007

Conference Publication

Vaccine against schistosomiasis: The role of a new tegument protein Sm29 on human and murine protective immune responses

Cardoso, F. C., Gava, E., Macedo, G. C., Kitten, G. T., Mello, A. L., Caliari, M. V. and Oliveira, S. C. (2007). Vaccine against schistosomiasis: The role of a new tegument protein Sm29 on human and murine protective immune responses. 13th International Congress of Immunology, Rio de Janeiro, Brazil, 21-25 August 2007.

Vaccine against schistosomiasis: The role of a new tegument protein Sm29 on human and murine protective immune responses

2006

Journal Article

Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis

Cardoso, F. C., Pinho, J. M. R., Azevedo, V. and Oliveira, S. C. (2006). Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis. Genetics and Molecular Research, 5 (4), 609-618.

Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis

2006

Journal Article

Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies

Cardoso, F. C., Pacífico, R. N. A., Mortara, R. A. and Oliveira, S. C. (2006). Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clinical and Experimental Immunology, 144 (3), 382-391. doi: 10.1111/j.1365-2249.2006.03081.x

Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies

2006

Other Outputs

Membrane protein Sm29 of schistosoma mansoni and uses thereof for treating and diagnosing schistosomiasis

Cardoso, Fernanda C. and Oliveira, Sergio C. (2006). Membrane protein Sm29 of schistosoma mansoni and uses thereof for treating and diagnosing schistosomiasis. WO2007118292A3.

Membrane protein Sm29 of schistosoma mansoni and uses thereof for treating and diagnosing schistosomiasis

2005

Conference Publication

Human IgG3 recognition of Schistosoma mansoni 29 kDa membrane bound protien identified by a bioinformatic approach

Cardoso, F. C., Pacifico, R. N. A. and Oliveira, S. C. (2005). Human IgG3 recognition of Schistosoma mansoni 29 kDa membrane bound protien identified by a bioinformatic approach. XLI Congress of Brazilian Society of Tropical Medicine, Florianopolis, Brazil, 6-10 March 2005.

Human IgG3 recognition of Schistosoma mansoni 29 kDa membrane bound protien identified by a bioinformatic approach

2003

Journal Article

Molecular cloning and characterization of Phoneutria nigriventer toxins active on calcium channels

Cardoso, F. C., Pacífico, L. G., Carvalho, D. C., Victoria, J. M. N., Neves, A. L. G., Chavez-Olortegui, C., Gomez, M. V. and Kalapothakis, E. (2003). Molecular cloning and characterization of Phoneutria nigriventer toxins active on calcium channels. Toxicon, 41 (7), 755-763. doi: 10.1016/S0041-0101(03)00011-4

Molecular cloning and characterization of Phoneutria nigriventer toxins active on calcium channels

Funding

Current funding

  • 2023 - 2026
    Peptide Inhibitors Targeting Sodium Channels to Treat Amyotrophic Lateral Sclerosis
    United States Congressionally Directed Medical Research Programs - Amyotrophic Lateral Sclerosis Research Program
    Open grant

Past funding

  • 2020 - 2023
    Novel multifunctional analgesic sodium channel inhibitors
    NHMRC IDEAS Grants
    Open grant
  • 2018 - 2019
    Development of dual Nav1.1/1.7 inhibitors for the treatment of IBS-related pain
    UniQuest Pty Ltd
    Open grant

Supervision

Availability

Dr Fernanda Cardoso is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Selective modulation voltage gated sodium channels to investigate pathophysiology and treatment for motor neuron disease

    Principal Advisor

Completed supervision

Media

Enquiries

Contact Dr Fernanda Cardoso directly for media enquiries about:

  • Analgesics
  • Bio-active peptides
  • Drug discovery
  • Ion channels
  • Irritable bowel syndrome
  • Motor Neuron Disease
  • Neurodegeneration
  • Neurological disorders
  • Pain
  • Snake
  • Spider
  • Toxins
  • Venoms

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au